Hasmet A Hanagasi
Overview
Explore the profile of Hasmet A Hanagasi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
433
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Radefeldt M, Lemke S, Chaichoompu K, Paul J, Curado F, Valzania F, et al.
Mov Disord
. 2024 Oct;
40(1):147-151.
PMID: 39460989
Background: The p.Ser71Arg RAB32 variant was recently associated with Parkinson's disease (PD). Objective: The aim was to investigate the presence of RAB32 variants in a large multiethnic group of individuals...
2.
Magrinelli F, Tesson C, Angelova P, Salazar-Villacorta A, Rodriguez J, Scardamaglia A, et al.
medRxiv
. 2024 Aug;
PMID: 39148840
Dissecting biological pathways highlighted by Mendelian gene discovery has provided critical insights into the pathogenesis of Parkinson's disease (PD) and neurodegeneration. This approach ultimately catalyzes the identification of potential biomarkers...
3.
Westenberger A, Skrahina V, Usnich T, Beetz C, Vollstedt E, Laabs B, et al.
Brain
. 2024 Aug;
147(8):2652-2667.
PMID: 39087914
Estimates of the spectrum and frequency of pathogenic variants in Parkinson's disease (PD) in different populations are currently limited and biased. Furthermore, although therapeutic modification of several genetic targets has...
4.
Samanci B, Sahin E, Samanci Y, Bilgic B, Atasu B, Lohmann E, et al.
Mov Disord Clin Pract
. 2024 Feb;
11(2):184-187.
PMID: 38386491
No abstract available.
5.
Traschutz A, Adarmes-Gomez A, Anheim M, Baets J, Brais B, Gagnon C, et al.
Ann Neurol
. 2023 May;
94(3):470-485.
PMID: 37243847
Objective: The Scale for the Assessment and Rating of Ataxia (SARA) is the most widely applied clinical outcome assessment (COA) for genetic ataxias, but presents metrological and regulatory challenges. To...
6.
Sumbul-Sekerci B, Bilgic B, Pasin O, Emre M, Hanagasi H
Dement Geriatr Cogn Disord
. 2022 Oct;
51(5):386-395.
PMID: 36273437
Introduction: Anticholinergic burden may be an important risk factor for the cognitive impairment. Especially in polypharmacy, even drugs with low anticholinergic effects may contribute to a significant anticholinergic burden. The...
7.
Koca S, Kiris I, Sahin S, Cinar N, Karsidag S, Hanagasi H, et al.
Neurosci Lett
. 2022 Jul;
786:136799.
PMID: 35842208
Alzheimer's Disease (AD) is a neurodegenerative disease characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain. However, increasing evidence suggests that the pathogenesis of the disease...
8.
Sumbul-Sekerci B, Hanagasi H, Bilgic B, Tufekcioglu Z, Gurvit H, Emre M
Acta Neurol Belg
. 2022 Mar;
123(3):823-829.
PMID: 35325434
Introduction: The key feature that distinguishes mild cognitive impairment (MCI) from dementia is the absence of significant functional decline because of cognitive impairment. In Parkinson's disease patients (PD) with MCI...
9.
Emekli I, Tepgec F, Samanci B, Toksoy G, Hasanogullari Kina G, Tufekcioglu Z, et al.
Parkinsonism Relat Disord
. 2021 Nov;
93:35-39.
PMID: 34781237
Introduction: The majority of Parkinson's disease (PD) ensue late-onset with a complex spectrum of environmental and genetic risk factors. Awareness of genetic causes in patients with PD is essential for...
10.
Emekli A, Hanagasi H
Noro Psikiyatr Ars
. 2021 Sep;
58(3):253-254.
PMID: 34526851
Hiccup is described as the sudden involuntary contraction of the diaphragm, and the intercostal muscles followed by the immediate closure of the glottis. Corticosteroids, benzodiazepines, and antibiotics may cause drug-induced...